705262-55-1 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
6-Bromoimidazo[1,2-a]pyridin-3-amine is used as a key intermediate in the synthesis of pharmaceuticals and agrochemicals, particularly for the development of kinase inhibitors. Its unique structure allows for the creation of potent and selective inhibitors, which can be used to target specific enzymes involved in various diseases.
Used in Cancer Treatment Research:
6-Bromoimidazo[1,2-a]pyridin-3-amine has been studied for its potential use in the treatment of cancer. Its ability to inhibit kinases, which are often dysregulated in cancer cells, makes it a promising candidate for the development of targeted cancer therapies. Further research is needed to explore its efficacy and safety in clinical settings.
Used as a Building Block in Organic Chemistry:
6-Bromoimidazo[1,2-a]pyridin-3-amine has been investigated for its role as a building block in the creation of novel chemical compounds. Its unique structure and functional groups make it a valuable component in the synthesis of new compounds with various applications in the field of organic chemistry, including the development of new materials, catalysts, and sensors.
Check Digit Verification of cas no
The CAS Registry Mumber 705262-55-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,0,5,2,6 and 2 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 705262-55:
(8*7)+(7*0)+(6*5)+(5*2)+(4*6)+(3*2)+(2*5)+(1*5)=141
141 % 10 = 1
So 705262-55-1 is a valid CAS Registry Number.
705262-55-1Relevant articles and documents
A sustainable and scalable multicomponent continuous flow process to access fused imidazoheterocycle pharmacophores
Baker, Blake J. M.,Kerr, William J.,Lindsay, David M.,Patel, Vipulkumar K.,Poole, Darren L.
, p. 280 - 287 (2021)
Described herein is a green, continuous flow process for the synthesis of various aminoimidazoheterocycles, through the Gr?ebke-Blackburn-Bienaymé reaction (GBBR). This multicomponent procedure combines aminoazines, aldehydes and isocyanides to generate a
NOVEL COMPOUNDS AS PHARMACEUTICAL AGENTS
-
Page 44, (2010/02/07)
The current invention relates to compounds of the formula:(Ia) and the pharmaceutically acceptable salts thereof and their use as TGF-beta signal transduction inhibitors for treating cancer and other diseases in a patient in need thereof by administration of said compounds.
